PAGNAN, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.930
AS - Asia 1.959
EU - Europa 1.101
AF - Africa 517
SA - Sud America 461
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 23
Totale 9.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.674
SG - Singapore 723
CN - Cina 345
BR - Brasile 295
HK - Hong Kong 232
VN - Vietnam 165
DE - Germania 142
FI - Finlandia 104
SE - Svezia 82
GB - Regno Unito 75
UA - Ucraina 73
IT - Italia 56
RU - Federazione Russa 52
FR - Francia 47
PL - Polonia 44
BJ - Benin 33
NL - Olanda 32
MX - Messico 30
EC - Ecuador 29
AT - Austria 28
ID - Indonesia 28
TR - Turchia 28
AR - Argentina 27
IN - India 25
CI - Costa d'Avorio 23
IE - Irlanda 23
ZA - Sudafrica 23
JP - Giappone 22
CA - Canada 21
LV - Lettonia 21
RO - Romania 21
UG - Uganda 21
PK - Pakistan 20
SA - Arabia Saudita 20
ES - Italia 19
MA - Marocco 19
SK - Slovacchia (Repubblica Slovacca) 19
TN - Tunisia 19
DJ - Gibuti 18
DZ - Algeria 18
JO - Giordania 17
NI - Nicaragua 17
PE - Perù 17
TH - Thailandia 17
AE - Emirati Arabi Uniti 16
AO - Angola 16
AZ - Azerbaigian 16
BO - Bolivia 16
DK - Danimarca 16
IQ - Iraq 16
IR - Iran 16
KR - Corea 16
NP - Nepal 16
PY - Paraguay 16
RS - Serbia 16
SI - Slovenia 16
UZ - Uzbekistan 16
CL - Cile 15
CR - Costa Rica 15
CW - ???statistics.table.value.countryCode.CW??? 15
KH - Cambogia 15
ML - Mali 15
MN - Mongolia 15
NO - Norvegia 15
PH - Filippine 15
PR - Porto Rico 15
PT - Portogallo 15
UY - Uruguay 15
CG - Congo 14
CU - Cuba 14
CZ - Repubblica Ceca 14
IL - Israele 14
KG - Kirghizistan 14
LA - Repubblica Popolare Democratica del Laos 14
MG - Madagascar 14
NC - Nuova Caledonia 14
SO - Somalia 14
AU - Australia 13
BG - Bulgaria 13
BW - Botswana 13
CH - Svizzera 13
EE - Estonia 13
EG - Egitto 13
GH - Ghana 13
HR - Croazia 13
JM - Giamaica 13
ME - Montenegro 13
NZ - Nuova Zelanda 13
PA - Panama 13
RW - Ruanda 13
BA - Bosnia-Erzegovina 12
BF - Burkina Faso 12
DO - Repubblica Dominicana 12
GR - Grecia 12
GT - Guatemala 12
LC - Santa Lucia 12
MY - Malesia 12
NG - Nigeria 12
SD - Sudan 12
VC - Saint Vincent e Grenadine 12
Totale 8.552
Salva come PNG Salva come JPEG
Città #
Fairfield 664
Ashburn 475
Singapore 391
Chandler 339
Houston 325
Woodbridge 323
Jacksonville 296
Seattle 259
Cambridge 241
Wilmington 227
Hong Kong 224
Ann Arbor 209
Princeton 125
Santa Clara 117
Beijing 110
Boardman 85
Dong Ket 62
San Diego 58
Roxbury 45
Nanjing 39
Ho Chi Minh City 38
Los Angeles 33
Helsinki 32
Cotonou 30
Des Moines 28
Hanoi 25
Buffalo 24
São Paulo 24
Chicago 23
Abidjan 22
Bytom 21
Kampala 20
New York 20
London 18
Amman 17
Managua 17
Dublin 16
Baku 15
Ulan Bator 15
Bamako 14
Djibouti 14
Quito 14
Riga 14
Kigali 13
Phnom Penh 13
Tashkent 13
Antananarivo 12
Bishkek 12
Castries 12
Harare 12
Havana 12
Kingstown 12
Montevideo 12
Noumea 12
Panama City 12
Podgorica 12
Rio de Janeiro 12
Tokyo 12
Vienna 12
Vientiane 12
Accra 11
Bangkok 11
Dar es Salaam 11
Jiaxing 11
Kingston 11
Lima 11
Milan 11
San José 11
Warsaw 11
Asunción 10
Johannesburg 10
Ljubljana 10
Luanda 10
Ouagadougou 10
Reykjavik 10
Tallinn 10
Tunis 10
Washington 10
Willemstad 10
Andorra la Vella 9
Changsha 9
Gaborone 9
Hebei 9
Hefei 9
Lusaka 9
Mexico City 9
Munich 9
Nairobi 9
Norwalk 9
Port Moresby 9
Shenyang 9
Sofia 9
Auckland 8
Belgrade 8
Bridgetown 8
Cayenne 8
Conakry 8
Council Bluffs 8
Dakar 8
Jeddah 8
Totale 5.695
Salva come PNG Salva come JPEG
Nome #
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score 242
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 239
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 234
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 210
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor 200
Acute oppressive chest pain in a 66-year-old woman with a recent Amplatzer device closure of patent foramen ovale 199
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients 188
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 188
Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. 183
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 181
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 181
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 177
von Willebrand factor abnormalities in aortic valve stenosis:pathophysiology and impact on bleeding. 176
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 167
ARE HODGKIN AND NON HODGKIN PATIENTS TO A GREATER RISK OF ATHEROSCLEROSIS? A FOLLOW UP OF 3YEARS 163
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 160
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 159
Comparison of methods for determination ofglomerular filtration rate in hypertensive subjects with normal serum creatinine 158
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 155
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 152
Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts 151
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 146
Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome 145
The natural history of hypertension in turkeys. 141
Inactivation of vascular smooth muscle cells photosensitised by liposome-delivered Zn(II)-phthalocyanine 140
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. 140
The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns 139
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 138
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 137
Cerebral venous thrombosis as rare onset of Churg-Strauss syndrome 137
Identifying type Vicenza von Willebrand disease 135
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 133
Local photodynamic therapy with Zn(II)-phthalocyanine in an experimental model of intimal hyperplasia 129
An apparent silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. 128
Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys236Phe mutation in the B2 domain 128
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 127
Carotid plaque morphology and cerebrovascular events 125
THE LONG TERM CLINICAL COURSE OF ACUTE DEEP VEIN THROMBOSIS OF THE ARM: PROSPECTIVE COHORT STUDY 123
Cardiovascular risk factors and ultrasound evaluation of intima media thickness at common carotids, carotid bulbs, femoral and abdominal aorta arteries in patients with classic Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency. 120
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial 119
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation 117
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. 116
Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis Findings from a cross-sectional survey 112
Role of PAI-1 in the differential diagnosis of hepatic veno-occlusive disease complicating hematopoietic stem cell transplantation: study in a pediatric population 110
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis 110
Time course of apoptosis and proliferation in vascular smooth muscle cells after balloon angioplasty 107
Therapeutic, hemodynamic, and metabolic effects of hyperbaric oxygenation in peripheral vascular disease. 107
Endothelial dysfunction in haemophilia patients. 105
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 105
The value of 64-detector row computed tomography for the exclusion of pulmonary embolism 103
An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia 101
Percutaneous excimer laser angioplasty of lower limb vessels: Results of a prospective 24-month follow-up 99
Intimal medial thickening of common carotid artery as indicator of coronary artery disease 97
[Feasibility of a program of moderate restriction of sodium using salt with low contents of sodium and dietetic prescriptions]. 97
Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population 97
Serum lipoproteins and atherosclerosis in hypertensive broad breasted white turkeys. 95
Postthrombotic syndrome 92
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 92
Recurrent thromboembolism in cancer patients: incidence and risk factors. 88
Therapeutic indications for acute venous thromboembolism. Current status and future perspectives 85
Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenolol. 84
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism 79
Apoptosi e ristenosi 78
Cerebrovascular diseases 73
Increased susceptibility of LDL to oxidation in patients with carotid atherosclerosis 70
Evidence of postprandial absorption of olive oil phenols in humans. 70
Prevalence of carotid and coronary artery disease in asymptomatic patients at high risk for atherosclerosis 67
The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S 62
Prevalence of occult pulmonary embolism in deep venous thrombosis of the lower extremities 61
Totale 9.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.038
article - articoli 27.706
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021560 0 0 0 0 0 119 16 77 123 55 89 81
2021/2022809 27 98 98 50 34 51 32 94 39 9 121 156
2022/2023658 130 83 7 68 109 98 0 42 81 3 31 6
2023/2024311 14 67 42 24 34 26 19 12 9 6 31 27
2024/20251.422 0 81 63 70 213 53 81 100 116 57 215 373
2025/20263.088 238 457 820 973 541 59 0 0 0 0 0 0
Totale 9.072